Evidence map›Paper›PMID 34035082›Full record

ArticleCancer research2021

Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.

Chang-Lung Lee, Kennedy D Brock, Stephanie Hasapis, Dadong Zhang, Alexander B Sibley, Xiaodi Qin, Jeremy S Gresham, Isibel Caraballo, Lixia Luo, Andrea R Daniel and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of p53 in Regulating Radiation Responses.Life (Basel, Switzerland) · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Chang-Lung Lee *Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. david.kirsch@duke.edu chang-lung.lee@duke.edu.ORCID 0000-0002-0673-633X
Kennedy D BrockDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-4926-7422
Stephanie HasapisDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Dadong ZhangDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Alexander B SibleyDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0003-4552-1865
Xiaodi QinDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Jeremy S GreshamDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Isibel CaraballoDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Lixia LuoDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Andrea R DanielDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0003-2186-5911
Matthew J HiltonDepartment of Orthopedic Surgery, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0003-3165-267X
Kouros OwzarDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
David G Kirsch *Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. david.kirsch@duke.edu chang-lung.lee@duke.edu.ORCID 0000-0002-2086-205X
Duke Medical Center · USDuke University · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8M
Advancing Cancer Therapy through Ground Breaking Research in Radiation BiologyR35CA197616 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI David Guy Kirsch · 2016 to 2026
$10.7M
Notch Signaling in Endochondral Bone DevelopmentR01AR071722 · NIAMS · DUKE UNIVERSITY · PI HILTON, MATTHEW J. · 2018 to 2022
$1.8M
Ionizing radiation promotes clonal expansion of premalignant cells in the thymusR00CA212198 · NCI · DUKE UNIVERSITY · PI LEE, CHANG-LUNG · 2018 to 2020
$747k
Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymusK99CA212198 · NCI · DUKE UNIVERSITY · PI LEE, CHANG-LUNG · 2016 to 2017
$229k
NCI NIH HHS K99 CA212198NCI NIH HHS P30 CA014236NCI NIH HHS R00 CA212198NCI NIH HHS R35 CA197616NIAMS NIH HHS R01 AR071722
6 · The paper itself

Abstract

Mouse models of radiation-induced thymic lymphoma are widely used to study the development of radiation-induced blood cancers and to gain insights into the biology of human T-cell lymphoblastic leukemia/lymphoma. Here we aimed to identify key oncogenic drivers for the development of radiation-induced thymic lymphoma by performing whole-exome sequencing using tumors and paired normal tissues from mice with and without irradiation. Thymic lymphomas from irradiated wild-type (WT), p53

Indexed as

AnimalsDisease Models, AnimalExome SequencingFemaleLymphomaMaleMiceReceptor, Notch1Thymus NeoplasmsTumor Suppressor Protein p53Notch1 protein, mouseReceptor, Notch1Tumor Suppressor Protein p53

Identifiers

PMID34035082
PMCPMC8286346
OpenAlexW3165070399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.